Follow The Filings

TLSI TriSalus Life Sciences

TriSalus Life Sciences earnings company data as of 4:47 AM ET 10/22

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by TLSI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TLSI insider trades
  • $3.6M bought by 6 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Mats Wahlstrom Director
    Buy
    $152K 60,000 shares at $2.53 +69% to stake
    Traded May 15 Filed May 18
    ↗
  2. Michael P Stansky Director
    Buy
    $1.5M 610,000 shares at $2.50
    Traded May 15 Filed May 18
    ↗
  3. Mary T Szela CEO
    Buy
    $103K 39,682 shares at $2.59 +3.9% to stake
    Traded May 15 Filed May 18
    ↗
  4. David Patience CFO
    Buy
    $17K 7,100 shares at $2.43 +2.6% to stake
    Traded May 15 Filed May 18
    ↗
  5. Gary B. Gordon Director
    Buy
    $25K 10,000 shares at $2.46 +16% to stake
    Traded May 15 Filed May 18
    ↗
  6. David Patience CFO
    Buy
    $15K 3,657 shares at $4.10 +1.4% to stake
    Traded Feb 23 Filed Feb 23
    ↗
  7. Gary B. Gordon Director
    Buy
    $40K 9,756 shares at $4.10 New stake
    Traded Feb 23 Filed Feb 23
    ↗
  8. William Valle Director
    Buy
    $125K 30,487 shares at $4.10 New stake
    Traded Feb 23 Filed Feb 23
    ↗
  9. Michael P Stansky Director
    Buy
    $1.5M 361,098 shares at $4.10
    Traded Feb 23 Filed Feb 23
    ↗

Also filed in the last 12 months, not counted as buying or selling: 21 stock grants, 18 sales to cover taxes, and 2 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.